Nine more cases of meningitis reported in US outbreak

By REUTERS
November 2, 2012 01:54
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Nine more cases of deadly fungal meningitis were reported from an outbreak tied to steroid medications shipped by a Massachusetts company, bringing the national total to 377 cases, US health officials said on Thursday.

No new deaths were reported on Thursday and the Centers for Disease Control and Prevention said Virginia had revised down the number of deaths there to two from three, reducing the national fatality total to 28. The CDC gave no reason for the revision.

In addition to the 377 cases of meningitis, the CDC said there also were nine reported cases of infections after a potentially contaminated steroid was injected into a joint such as a knee, hip, shoulder or elbow, bringing the total number of infections nationwide to 386.

The steroid was supplied by New England Compounding Center of Massachusetts, which faces multiple investigations. Health authorities have said its facility near Boston failed to make medications in sterile conditions. A fungus was found in some of the vials of steroid produced by the company and bacteria was found in other drugs from the facility.

A sister company of NECC, Ameridose, on Wednesday recalled all of its products in a move to cooperate with authorities. The recall could lead to shortages of some drugs.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Breaking news
November 16, 2018
Sinwar delivers message of aggression towards Israel after cease-fire

By YASSER OKBI/MAARIV